Page last updated: 2024-10-29

ketanserin and Feeding and Eating Disorders

ketanserin has been researched along with Feeding and Eating Disorders in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Feeding and Eating Disorders: A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
StrĂ¼der, HK1
Weicker, H1

Reviews

1 review available for ketanserin and Feeding and Eating Disorders

ArticleYear
Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part II.
    International journal of sports medicine, 2001, Volume: 22, Issue:7

    Topics: Amino Acids, Branched-Chain; Animals; Binding Sites; Biological Transport; Blood Platelets; Caffeine

2001